专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US08980583B2 Cells deficient in CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase 有权
标题翻译：缺乏CMP-N-乙酰神经氨酸羟化酶和/或糖蛋白α-1,3-半乳糖基转移酶的细胞
公开(公告)号：US08980583B2
公开(公告)日：2015-03-17
申请号：US13538825
申请日：2012-06-29
申请人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
发明人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
IPC分类号： C12N5/10 , C12N9/02 , C12P21/00 , C12N9/10
CPC分类号： C12P21/005 , C12N9/0071 , C12N9/1051 , C12N2510/00 , C12N2510/02 , C12N2510/04 , C12Y114/18002
摘要： The present invention provides non-human mammalian cell lines that are deficient in CMP-Neu5Ac hydroxylase (Cmah) and/or glycoprotein alpha-1,3-galactosyltransferase (Ggta1). Also provided are methods for using the cells disclosed herein for producing recombinant proteins with human-like patterns of glycosylation.
摘要翻译：本发明提供缺乏CMP-Neu5Ac羟化酶（Cmah）和/或糖蛋白α-1,3-半乳糖基转移酶（Ggta1）的非人哺乳动物细胞系。还提供了使用本文公开的细胞来生产具有人类糖基化模式的重组蛋白质的方法。

2. 发明申请

US20150152463A1 CELLS DEFICIENT IN CMP-N-ACETYLNEURAMINIC ACID HYDROXYLASE AND/OR GLYCOPROTEIN ALPHA-1,3-GALACTOSYLTRANSFERASE 审中-公开
标题翻译： CMP- N-乙酰氨基酸羟化酶和/或谷氨酰胺ALPHA-1,3-糖蛋白酶的细胞缺失
公开(公告)号：US20150152463A1
公开(公告)日：2015-06-04
申请号：US14609603
申请日：2015-01-30
申请人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
发明人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
IPC分类号： C12P21/00
CPC分类号： C12P21/005 , C12N9/0071 , C12N9/1051 , C12N2510/00 , C12N2510/02 , C12N2510/04 , C12Y114/18002
摘要： The present invention provides non-human mammalian cell lines that are deficient in CMP-Neu5Ac hydroxylase (Cmah) and/or glycoprotein alpha-1,3-galactosyltransferase (Ggta1). Also provided are methods for using the cells disclosed herein for producing recombinant proteins with human-like patterns of glycosylation.
摘要翻译：本发明提供缺乏CMP-Neu5Ac羟化酶（Cmah）和/或糖蛋白α-1,3-半乳糖基转移酶（Ggta1）的非人哺乳动物细胞系。还提供了使用本文公开的细胞来生产具有人类糖基化模式的重组蛋白质的方法。

3. 发明授权

US09062338B1 Method of producing human-like glycosylation pattern using cells deficient in glutamine synthase, CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase 有权
标题翻译：使用缺乏谷氨酰胺合成酶，CMP-N-乙酰神经氨酸羟化酶和/或糖蛋白α-1,3-半乳糖基转移酶的细胞产生人样糖基化模式的方法
公开(公告)号：US09062338B1
公开(公告)日：2015-06-23
申请号：US14609603
申请日：2015-01-30
申请人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
发明人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
IPC分类号： C12P21/00
CPC分类号： C12P21/005 , C12N9/0071 , C12N9/1051 , C12N2510/00 , C12N2510/02 , C12N2510/04 , C12Y114/18002
摘要： The present invention provides non-human mammalian cell lines that are deficient in CMP-Neu5Ac hydroxylase (Cmah) and/or glycoprotein alpha-1,3-galactosyltransferase (Ggta1). Also provided are methods for using the cells disclosed herein for producing recombinant proteins with human-like patterns of glycosylation.
摘要翻译：本发明提供缺乏CMP-Neu5Ac羟化酶（Cmah）和/或糖蛋白α-1,3-半乳糖基转移酶（Ggta1）的非人哺乳动物细胞系。还提供了使用本文公开的细胞来生产具有人类糖基化模式的重组蛋白质的方法。

4. 发明申请

US20130004992A1 CELLS DEFICIENT IN CMP-N-ACETYLNEURAMINIC ACID HYDROXYLASE AND/OR GLYCOPROTEIN ALPHA-1,3-GALACTOSYLTRANSFERASE 有权
公开(公告)号：US20130004992A1
公开(公告)日：2013-01-03
申请号：US13538825
申请日：2012-06-29
申请人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
发明人： Nan Lin , Henry J. George , Joaquina Mascarenhas , Trevor N. Collingwood , Kevin J. Kayser , Katherine Achtien
IPC分类号： C12N5/10 , C12P21/00
CPC分类号： C12P21/005 , C12N9/0071 , C12N9/1051 , C12N2510/00 , C12N2510/02 , C12N2510/04 , C12Y114/18002
摘要： The present invention provides non-human mammalian cell lines that are deficient in CMP-Neu5Ac hydroxylase (Cmah) and/or glycoprotein alpha-1,3-galactosyltransferase (Ggta1). Also provided are methods for using the cells disclosed herein for producing recombinant proteins with human-like patterns of glycosylation.

5. 发明授权

US4673641A Co-aggregate purification of proteins 失效
标题翻译：蛋白质的共聚合纯化
公开(公告)号：US4673641A
公开(公告)日：1987-06-16
申请号：US573642
申请日：1984-01-25
申请人： Henry J. George , Richard A. Krzyzek , Lynn W. Enquist , Roger J. Watson
发明人： Henry J. George , Richard A. Krzyzek , Lynn W. Enquist , Roger J. Watson
IPC分类号： A61K39/00 , A61K39/245 , C12N15/66 , C12N15/70 , C12P21/04 , C12P21/00 , C07K3/24 , C12N1/00 , C12N1/02 , C12N15/00 , C12P21/02
CPC分类号： C12N15/70 , C12N15/66 , A61K39/00 , C07K2319/00 , C07K2319/02 , C07K2319/61 , C07K2319/75
摘要： Methods are provided for stabilization and purification of proteins produced in host cell systems. The methods provide for significant stabilization of any unfused non-bacterial protein that is produced in the same host cell that is producing an aggregate-forming fusion protein or any aggregate-forming protein.
摘要翻译：提供了用于稳定和纯化在宿主细胞系统中产生的蛋白质的方法。所述方法提供在产生聚集体形成融合蛋白或任何聚集体形成蛋白质的相同宿主细胞中产生的任何未融合的非细菌蛋白质的显着稳定化。

6. 发明授权

US06623981B2 Detection of patients at risk for developing integrin antagonist/agonist mediated disease states 有权
标题翻译：检测患有发展为整合素拮抗剂/激动剂介导的疾病状态的患者
公开(公告)号：US06623981B2
公开(公告)日：2003-09-23
申请号：US09237061
申请日：1999-01-26
申请人： Jeffrey T. Billheimer , Dietmar A. Seiffert , Leah A. Breth , Timothy C. Burn , Ira B. Dicker , Henry J. George , Gregory F. Hollis , Jeannine M. Hollis , Jennifer E. Kochie , Karyn T. O'Neil
发明人： Jeffrey T. Billheimer , Dietmar A. Seiffert , Leah A. Breth , Timothy C. Burn , Ira B. Dicker , Henry J. George , Gregory F. Hollis , Jeannine M. Hollis , Jennifer E. Kochie , Karyn T. O'Neil
IPC分类号： G01N33553
CPC分类号： G01N33/6893 , C07K14/70557 , C07K16/2848 , G01N33/566 , G01N33/68 , G01N2333/70546 , G01N2500/00 , Y10S435/968 , Y10S436/811
摘要： This invention relates to the detection of patients at risk for developing integrin antagonist/agonist mediated disease states. This invention relates to assays useful for the detection in a patient bodily fluid sample of drug-dependent antibodies which bind to integrins, or intergrin-associated proteins or complexes thereof in the presence of an integrin antagonist/agonist. This invention also relates to assays useful for the detection in a patient bodily fluid sample of drug-dependent antibodies (DDABS) that bind to integrins, including the platelet glycoprotein IIb/IIIa (GPIIb/IIIa), in the presence of a integrin agonist and/or antagonist. This invention also relates to procedures for identifying integrin antagonists/agonists that are less prone to elicit integrin antagonist/agonist mediated disease states. This invention also relates to procedures which increase the recovery of integrin-directed antibodies in body fluids, resulting in an increased sensitivity and specificity of DDAB detection assays. This invention also relates to procedures for treating blood samples, which dissociate antibodies to GPIIb/IIIa from the platelet surface, thereby increasing the recovery from the platelet supernatant. This invention also relates to the use of different GPIIb/IIIa preparations to identify patients at risk for early-onset thrombocytopenia upon treatment with GPIIb/IIIa antagonist/agonists, thereby increasing the specificity of antibody detection. This invention also relates to the use of DDABs as a positive control and calibration standard for DDAB assays. Such methods, procedures and assays are useful for identifying patients who may be at risk to develop disease states mediated by treatment with integrin antagonists/agonists.
摘要翻译：本发明涉及检测发展为整合素拮抗剂/激动剂介导的疾病状态的风险的患者。本发明涉及可用于在整联蛋白拮抗剂/激动剂存在下结合整联蛋白或整合蛋白相关蛋白或其复合物的药物依赖性抗体的患者体液样品中的检测。本发明还涉及用于在整联蛋白激动剂存在下结合整联蛋白（包括血小板糖蛋白IIb / IIIa（GPIIb / IIIa））的药物依赖性抗体（DDABS）的患者体液样品中检测的测定法， /或拮抗剂。本发明还涉及识别不易引起整联蛋白拮抗剂/激动剂介导的疾病状态的整联蛋白拮抗剂/激动剂的方法。本发明还涉及增加体液中整联蛋白定向抗体的回收率的方法，导致敏感性增加和DDAB检测测定的特异性。本发明还涉及用于治疗血液样品的方法，其从血小板表面解离GPIIb / IIIa的抗体，从而增加血小板上清液的回收。本发明还涉及使用不同的GPIIb / IIIa制剂来鉴定在用GPIIb / IIIa拮抗剂/激动剂治疗时患有早发性血小板减少症的患者，从而增加抗体检测的特异性。本发明还涉及使用DDAB 作为DDAB测定的阳性对照和校准标准。这些方法，程序和测定法可用于鉴定可能患有通过用整联蛋白拮抗剂/激动剂治疗介导的疾病状态的风险的患者。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式